Literature DB >> 305122

Human lymphocyte-mouse myeloma somatic cell hybrids: selective hybrid formation.

J Schwaber.   

Abstract

Fusion of unfractionated human lymphocytes with mouse myeloma cells resulted in proliferating hybrid colonies, almost all producting human Ig. We examined whether this high frequency of Ig production was the result of selective formation of human B lymphocyte-mouse myeloma hybrids, rather than induction of Ig genes in T lymphocytes. Unfractionated peripheral lymphocytes and B lymphocytes from patients with the common variable form of agammaglobulinemia formed proliferating somatic cell hybrid colonies. In contrast, peripheral lymphocytes from a patient with agammaglobulinema who lacked B lymphocytes, as well as albumin gradient fractions of peripheral blood which do not contain B lymphocytes, failed to produce somatic cell hybrids with three different myeloma parent cell lines. B, T, and precursor lymphocytes all had Sendai virus receptors, as witnessed by viral agglutination. We conclude that fusion of human lymphocytes with mouse myeloma cells results in selective hybrid formation, rather than activation of Ig genes in disparate cell types. Only B lymphocyte-mouse myeloma heterokaryons form hybrid cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 305122     DOI: 10.1007/bf01538747

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  3 in total

1.  Human T cell hybridomas secreting immune interferon.

Authors:  J Le; J Vilcek; C Saxinger; W Prensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

2.  Expression of human adenosine deaminase after fusion of adenosine deaminase-deficient cells with mouse fibroblasts.

Authors:  M J Siciliano; M R Bordelon; P O Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Induction of human immunoglobulin synthesis and secretion in somatic cell hybrids of mouse myeloma and human B lymphocytes from patients with agammaglobulinemia.

Authors:  J F Schwaber; F S Rosen
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.